[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biodesix Inc (BDSX)

Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biodesix Inc 919 WEST DILLON RD. LOUISVILLE CO 80027 USA

www.biodesix.com Employees: 334 P: 303-417-0500 F: 866-432-3338

Sector:

Medical

Description:

Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 169,010
Enterprise Value, $K 197,480
Shares Outstanding, K 10,356
Float, K 7,953
% Float 76.80%
Short Interest, K 148
Short Float 1.46%
Days to Cover 2.53
Short Volume Ratio 0.23
% of Insider Shareholders 23.20%
% of Institutional Shareholders 20.96%

Financials:

Annual Sales, $ 88,500 K
Annual Net Income, $ -35,270 K
Last Quarter Sales, $ 25,560 K
Last Quarter Net Income, $ -7,790 K
EBIT, $ -24,900 K
EBITDA, $ -17,890 K

Growth:

1-Year Return 137.76%
3-Year Return -39.56%
5-Year Return -94.00%
5-Year Revenue Growth 94.25%
5-Year Earnings Growth 96.40%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.81 on 05/04/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -4.06
EPS Growth vs. Prev Qtr -65.31%
EPS Growth vs. Prev Year 49.38%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 09/15/25

BDSX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2,101.40%
Return-on-Assets % -35.65%
Profit Margin % -39.85%
Debt/Equity 5.09
Price/Sales 1.87
Price/Cash Flow N/A
Price/Book 17.70
Book Value/Share 0.90
Interest Coverage -3.57
60-Month Beta 0.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.